affiliate disclosure · We earn affiliate commission on some vendor links. Audits, scores, and rankings are independent — vendors do not pay for placement and do not see drafts. read more →
“Newer US-domestic vendor with third-party COAs that absorbed much of the post-Amino-Asylum migration. Strong public signals; first-hand audit pending.”
pros
+Third-party COAs published on every batch (Janoshik or comparable)
+US-domestic shipping with 2–4 day median per community reports
+Wide catalog spanning the GLP-1 mainstream + healing peptides
+Active customer-service presence in r/Peptides discussions
cons
−Newer vendor (founded post-2024) with shorter track record than incumbents
−Premium-tier pricing; not the cheapest option for any common SKU
−This profile is preview-data only — first-hand audit pending
For this preview profile we synthesized: approximately 60 r/Peptides
comments mentioning Ascension Peptides between January 2026 and April
2026; the vendor's published COAs on the GLP-1 SKUs (retatrutide,
tirzepatide, semaglutide); and Janoshik public-test entries where
available. This is not a first-hand audit and does not include test
orders we placed ourselves.
Why Ascension matters in 2026
Three of the top five US peptide vendors by traffic closed within twelve
months: Amino Asylum (June 2025, FDA raid), Paradigm Peptides
(December 2025, federal plea), and Peptide Sciences (March 2026,
quality collapse). The displaced buyer population — likely 400,000+
monthly visitors at peak — has migrated. Ascension Peptides was one
of the primary destinations.
The vendor profile that emerges from public data:
US-domestic operation: ships only within the US. Customs handling
not in scope. Domestic shipping reports cluster around 2–4 days.
COA practices: vendor publishes Janoshik or comparable
third-party COAs on most flagship SKUs, with batch IDs that match
individual vials. This is the practice we score highest in the
COA-quality subscore.
Catalog breadth: covers the four most-searched compounds
(retatrutide, tirzepatide, semaglutide, BPC-157) plus a tail of
healing and skin peptides.
Pricing: positioned at the upper-mid tier. Not the cheapest;
not a premium-only operation. Roughly 5–10% above the cycle median
on the GLP-1 SKUs we tracked.
Community sentiment
The dominant theme in r/Peptides comments was catalog-completeness
relative to closed vendors. Users displaced by Amino Asylum and
Peptide Sciences shutdowns repeatedly described Ascension as the
practical replacement: similar SKU coverage, similar price tier,
visibly more disciplined COA practices than Amino Asylum's later years.
Secondary themes included:
Customer-service responsiveness — described as "consistently within
the same business day" across multiple threads
Shipping speed — reported as faster than the cycle average for
US-domestic peptide vendors
Pricing — flagged as "fair, not cheap" by most commenters
The most-cited concern was track record length. Ascension is a
newer entrant; the historical reliability data points (multi-year COA
trend, regulatory clean record across multiple cycles) that older
vendors accumulated do not exist yet for this vendor.
What we'd verify in a full audit
When this profile graduates from public-data preview to full audit, the
specific dimensions we'd test:
Independent Janoshik HPLC + mass-spec on retatrutide and tirzepatide
samples; cross-reference vendor-stated COA against our independent
result within our 1.5-percentage-point tolerance
Three test orders placed under aliases through a US receiving
address; median dispatch and transit time logged
Customer-service response time tested with one realistic and one
deliberately confusing inquiry, business hours
Endotoxin and sterility verification on at least one batch (rare in
the niche; differentiates upper-tier vendors)
Sources
r/Peptides community threads (Jan–Apr 2026, ~60 comments synthesized)